scholarly journals Near final height in Korean children referred for evaluation of short stature: clinical utility and analytical validity of height prediction methods

2018 ◽  
Vol 23 (1) ◽  
pp. 28-32
Author(s):  
Seung Woo Jeong ◽  
Ja Hyang Cho ◽  
Hae Woon Jung ◽  
Kye Shik Shim
2004 ◽  
Vol 151 (Suppl_1) ◽  
pp. S41-S45 ◽  
Author(s):  
JM Wit ◽  
HV Balen ◽  
GA Kamp ◽  
W Oostdijk

Experiments of nature and clinical observations have provided indications that postponing puberty may increase final height in short children. In children with central precocious puberty, a GnRH analog (GnRHa) alone is efficacious in increasing final height, but in other conditions a combination of growth hormone (GH) and GnRHa is needed. In GH-deficient children with early onset of puberty and poor height prediction, the combination of GH and GnRHa increases final height by 1.0-1.3 s.d. In children with idiopathic short stature and persistent short stature after intrauterine growth retardation, the combination also appears to be beneficial. Potential side effects include weight gain, a negative effect on bone mineralization, and psychosocial consequences. More data on long-term safety have to be collected before the combination of GH and GnRHa in children with idiopathic short stature should be considered for clinical use outside clinical trials.


2021 ◽  
pp. 1-8
Author(s):  
İbrahim Mert Erbaş ◽  
Zeynep Ölmez ◽  
Ahu Paketçi ◽  
Korcan Demir ◽  
Ece Böber ◽  
...  

2007 ◽  
Vol 92 (7) ◽  
pp. 874-874
Author(s):  
M Hermanussen ◽  
TJ Cole Aschauhof
Keyword(s):  

2011 ◽  
pp. P1-747-P1-747
Author(s):  
Thais C Martins ◽  
Cristiane N Lauretti ◽  
Ivo JP Arnhold ◽  
Berenice B Mendonca ◽  
Alexander AL Jorge

2021 ◽  
Vol 185 (5) ◽  
pp. 629-635
Author(s):  
Aristeidis Giannakopoulos ◽  
Alexandra Efthymiadou ◽  
Dionisios Chrysis

Objective The diagnosis of growth hormone deficiency (GHD) in children is not always straightforward because insulin-like growth factor 1 (IGF-I) or GH stimulation tests may not be able to discriminate GHD from constitutional delay of growth and puberty (CDGP) or other causes of short stature. Design Boys and girls (n = 429, 0.7–16 years) who attended our department for short stature participated in this study. They were followed up for an average period of 9 years. At the end of follow-up after reaching the final height, a definitive diagnosis was assigned, and all the components of ternary complex (IGF-I, IGF-binding protein-3 (IGFBP-3), acid-labile subunit (ALS), and IGF-I/IGFBP-3 ratio) were evaluated as biomarkers for the respective diagnosis. Results All the components of the ternary complex were tightly correlated with each other and were positively related to age. IGF-I, IGFBP-3, ALS, and IGF-I/IGFBP-3 ratio differed significantly between GHD and normal groups. IGF-I and ALS levels were lower in GHD compared to children with familial short stature, while IGF-I and IGF-I/IGFBP-3 ratio was significantly lower in GHD compared to children with CDGP. IGF-I and IGF-I/IGFBP-3 receiver operating curve cutoff points were unable to discriminate between GHD and normal groups or between GHD and CDGP groups. Conclusion Despite the tight correlation among all the components of the ternary complex, each one shows a statistically significant diagnosis-dependent alteration. There is a superiority of IGF-I, ALS, and IGF-I/IGFBP-3 ratio in the distinction between GHD and CDGP or between GHD and normal groups but without usable discriminating power, making auxology as the primary criterion for establishing the diagnosis.


2008 ◽  
Vol 70 (2) ◽  
pp. 89-92 ◽  
Author(s):  
C.J. Elder ◽  
J.S. Barton ◽  
C.G.D. Brook ◽  
M.A. Preece ◽  
M.T. Dattani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document